These compounds may interact with:
Mucolipin-3
Potentially involved in: kidney cancer; carcinoma; gangliosidosis; adrenocortical carcinoma; atopic dermatitis; cutaneous lupus erythematosus; cystic fibrosis; ductal carcinoma in situ; interstitial cystitis; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); invasive ductal carcinoma; lung adenocarcinoma; lung cancer; medulloblastoma, large-cell; non-small cell lung cancer; osteosarcoma; ovarian cancer; pancreatic cancer; pituitary cancer
Disease data sourced from Pharos.